Vincent Andrews
Stock Analyst at Morgan Stanley
(3.86)
# 713
Out of 4,734 analysts
299
Total ratings
67.37%
Success rate
28.63%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Vincent Andrews
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TROX Tronox Holdings | Maintains: Equal-Weight | $16 → $12 | $9.97 | +20.36% | 11 | Jan 13, 2025 | |
| LYB LyondellBasell Industries | Maintains: Overweight | $110 → $90 | $77.30 | +16.43% | 9 | Jan 13, 2025 | |
| DOW Dow Inc. | Maintains: Equal-Weight | $59 → $46 | $41.04 | +12.09% | 15 | Jan 13, 2025 | |
| CC The Chemours Company | Maintains: Equal-Weight | $25 → $22 | $19.40 | +13.40% | 15 | Jan 13, 2025 | |
| CE Celanese | Maintains: Equal-Weight | $100 → $80 | $72.61 | +10.18% | 16 | Jan 13, 2025 | |
| ADM Archer-Daniels-Midland Company | Maintains: Equal-Weight | $57 → $52 | $51.29 | +1.38% | 17 | Nov 12, 2024 | |
| ECL Ecolab | Maintains: Equal-Weight | $240 → $263 | $237.42 | +10.77% | 14 | Oct 30, 2024 | |
| DD DuPont de Nemours | Maintains: Equal-Weight | $88 → $94 | $77.47 | +21.34% | 9 | Oct 21, 2024 | |
| SHW The Sherwin-Williams Company | Maintains: Overweight | $375 → $450 | $353.98 | +27.13% | 22 | Oct 18, 2024 | |
| CTVA Corteva | Maintains: Overweight | $65 | $62.32 | +4.30% | 11 | Sep 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $240 → $280 | $317.80 | -11.89% | 13 | Jun 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $90 → $81 | $97.49 | -16.91% | 11 | Mar 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $100 → $70 | $53.43 | +31.01% | 14 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $70 → $85 | $97.01 | -12.38% | 17 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $105 → $114 | $79.54 | +43.32% | 11 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $32 | $36.28 | -11.80% | 9 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $420 | $436.00 | -3.67% | 9 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $115 | $93.21 | +23.38% | 14 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $143 → $155 | $120.24 | +28.91% | 16 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $91 | $51.62 | +76.29% | 11 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $60 → $55 | $27.14 | +102.65% | 13 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $8.5 | $5.91 | +43.82% | 8 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $45 → $57 | $42.44 | +34.31% | 4 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $160 | $84.89 | +88.48% | 1 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $126.52 | - | 9 | Dec 14, 2020 |
Tronox Holdings
Jan 13, 2025
Maintains: Equal-Weight
Price Target: $16 → $12
Current: $9.97
Upside: +20.36%
LyondellBasell Industries
Jan 13, 2025
Maintains: Overweight
Price Target: $110 → $90
Current: $77.30
Upside: +16.43%
Dow Inc.
Jan 13, 2025
Maintains: Equal-Weight
Price Target: $59 → $46
Current: $41.04
Upside: +12.09%
The Chemours Company
Jan 13, 2025
Maintains: Equal-Weight
Price Target: $25 → $22
Current: $19.40
Upside: +13.40%
Celanese
Jan 13, 2025
Maintains: Equal-Weight
Price Target: $100 → $80
Current: $72.61
Upside: +10.18%
Archer-Daniels-Midland Company
Nov 12, 2024
Maintains: Equal-Weight
Price Target: $57 → $52
Current: $51.29
Upside: +1.38%
Ecolab
Oct 30, 2024
Maintains: Equal-Weight
Price Target: $240 → $263
Current: $237.42
Upside: +10.77%
DuPont de Nemours
Oct 21, 2024
Maintains: Equal-Weight
Price Target: $88 → $94
Current: $77.47
Upside: +21.34%
The Sherwin-Williams Company
Oct 18, 2024
Maintains: Overweight
Price Target: $375 → $450
Current: $353.98
Upside: +27.13%
Corteva
Sep 24, 2024
Maintains: Overweight
Price Target: $65
Current: $62.32
Upside: +4.30%
Jun 5, 2024
Maintains: Equal-Weight
Price Target: $240 → $280
Current: $317.80
Upside: -11.89%
Mar 11, 2024
Maintains: Underweight
Price Target: $90 → $81
Current: $97.49
Upside: -16.91%
Oct 24, 2023
Downgrades: Equal-Weight
Price Target: $100 → $70
Current: $53.43
Upside: +31.01%
Aug 7, 2023
Maintains: Equal-Weight
Price Target: $70 → $85
Current: $97.01
Upside: -12.38%
Aug 7, 2023
Maintains: Equal-Weight
Price Target: $105 → $114
Current: $79.54
Upside: +43.32%
Aug 4, 2023
Reiterates: Equal-Weight
Price Target: $32
Current: $36.28
Upside: -11.80%
Aug 1, 2023
Reiterates: Overweight
Price Target: $420
Current: $436.00
Upside: -3.67%
Aug 1, 2023
Reiterates: Overweight
Price Target: $115
Current: $93.21
Upside: +23.38%
Jul 24, 2023
Maintains: Equal-Weight
Price Target: $143 → $155
Current: $120.24
Upside: +28.91%
Jan 11, 2023
Maintains: Equal-Weight
Price Target: $100 → $91
Current: $51.62
Upside: +76.29%
Jan 11, 2023
Maintains: Equal-Weight
Price Target: $60 → $55
Current: $27.14
Upside: +102.65%
Jan 11, 2023
Maintains: Equal-Weight
Price Target: $12 → $8.5
Current: $5.91
Upside: +43.82%
May 12, 2021
Maintains: Equal-Weight
Price Target: $45 → $57
Current: $42.44
Upside: +34.31%
Apr 12, 2021
Reinstates: Overweight
Price Target: $160
Current: $84.89
Upside: +88.48%
Dec 14, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $126.52
Upside: -